Healthcare Equipment and Supplies
Company Overview of Acufocus, Inc.
Acufocus, Inc. provides near vision solutions. It offers AcuFocus KAMRA inlay, an implant to reverse the effects of presbyopia, and restore near and intermediate vision. The company offers its products in Europe, Asia, and South America. Acufocus, Inc. was founded in 2001 and is based in Irvine, California.
Irvine, CA 92618
Founded in 2001
Key Executives for Acufocus, Inc.
Chairman and Chief Executive Officer
Chief Commercialization Officer
Compensation as of Fiscal Year 2014.
Acufocus, Inc. Key Developments
Versant Ventures, Inc. Appoints James V. (Jim) Mazzo as Chairman and CEO of AcuFocus
Jul 12 13
Versant Ventures, announced that James V. (Jim) Mazzo, former CEO of Advanced Medical Optics (AMO) and Sr. VP of Abbott Labs, will serve as Chairman and CEO of AcuFocus, and as an advisor and board member to additional Versant portfolio companies. Since 2009, he has served as Senior Vice President, Abbott Laboratories and President, Abbott Medical Products, departing in May 2013 to join the company.
Acufocus, Inc. Submits Premarket Approval Application for the KAMRA Corneal Inlay with U.S. Food and Drug Administration
Mar 19 13
Acufocus, Inc. has submitted the final module of their premarket approval application (PMA) for the KAMRA corneal inlay to the U.S. Food and Drug Administration (FDA). Over time, everyone will experience loss of reading vision and blurriness, or presbyopia, as they age. The KAMRA corneal inlay is designed to revive reading vision by allowing only focused light to enter the eye. Patients who have undergone this procedure may regain the vision that they had prior to the presbyopia, are once again performing daily tasks such as reading text messages, checking the time on a wristwatch, reading store shelf prices, working on a computer and driving with ease without glasses. As a novel technology with no similar precedent in the market, the KAMRA inlay has undergone rigorous approval processes in several countries. The inlay is now approved in 47 countries across Europe, Asia-Pacific, Middle East, and the Americas, with most recent approvals in Canada. To date, nearly 20,000 KAMRA inlays have been implanted worldwide and over 150 surgeons have been certified to offer KAMRA Vision to their patients.
Acufocus, Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-09-2013 01:30 PM
Dec 29 12
Acufocus, Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-09-2013 01:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Edward Peterson, Chief Executive Officer and President.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|